Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: J Pharm Biomed Anal. 2021 Apr 22;201:114097. doi: 10.1016/j.jpba.2021.114097

Table 1.

Site-specific association equilibrium constants (Ka) measured for repaglinide at Sudlow sites I and II of normal or modified HSAa

Type of HAS Sudlow site I Ka (M−1) Change vs. Normal HSA Sudlow site II Ka (M−1)c Change vs. Normal HSA
Normal HSA 4.2 (± 0.3) × 104 ------ 6.1 (± 0.2) × 104 ------
GoHSA1 5.4 (± 0.5) × 104 ↑ 1.29-fold 1.4 (± 0.1) × 105 ↑ 2.30-fold
GoHSA2 7.2 (± 0.3) × 104 ↑ 1.71-fold 2.1 (± 0.4) × 105 ↑ 3.44-fold
MGoHSA1 3.8 (± 0.4) × 104 ↓ 9.5% (N.S.)b 1.8 (± 0.2) × 105 ↑ 2.95-fold
MGoHSA2 3.4 (± 0.4) × 104 ↓ 19% 2.2 (± 0.2) × 105 ↑ 3.61-fold
a

These results were measured at 37 °C in pH 7.4, 0.067 M potassium phosphate buffer. The values in parentheses represent a range of ± 1 S. D. Except were indicated otherwise, all changes shown for modified HSA vs. normal HSA were significant at the 95% confidence level based on the Student’s t-test.

b

The result for MGoHSA1 at Sudlow site I was not significantly different (N.S.) from normal HSA at the 95% confidence level but was significantly different at the 90% confidence level.

c

The listed result for normal HSA is consistent with values obtained for several columns and batches of silica that contained this immobilized binding agent.